During the past decade, Hudson-Essex Allergy conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hudson-Essex Allergy" #1 collaborator was "Dyax Corp." with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hudson-Essex Allergy" are "Hereditary Angioedema (HAE)" (3 trials), "Angioedema" (1 trials), "Hereditary Angioedema" (1 trials) and "Peanut Allergy" (1 trials). Many other conditions were trialed in "Hudson-Essex Allergy" in a lesser frequency.

Most popular intervention types in "Hudson-Essex Allergy" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "DX-2930" (1 trials), "DX-2930 - 150mg/4wk" (1 trials), "DX-2930 - 300mg/2wk" (1 trials) and "DX-2930 - 300mg/4wk" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hudson-Essex Allergy" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hudson-Essex Allergy". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hudson-Essex Allergy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hudson-Essex Allergy, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".